Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.
April 29, 2025 | Market Access, US, access and pricing, agile, efficient, global, solution
In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision.
Following Genesis Research Group’s recent expansion of its real-world data analytics capabilities and the appointment of Ki Park as VP, Market Access Strategy & Analytics, the innovative global HEOR, access & pricing and real-world evidence research organization has fully outlined its integrated market access offering.
Genesis Research Group leverages its proprietary RPR stakeholder engagement platform, a network of 3,500+ vetted payers, clinicians, and KOLs across 65 countries, coupled with deep expertise in access, pricing, HEOR, and real-world analytics, to deliver end-to-end solutions that drive commercial success.
Each of the following capabilities can be integrated to boost results or applied independently—helping clients to transform complex challenges throughout the product lifecycle into competitive advantages.
✅ Global strategic advisory
Navigate complex US and global challenges with clarity and confidence. The company’s experts partner with you to develop detailed strategies on product positioning, pricing, and value demonstration – maximizing commercial success through tailored, market-specific solutions.
✅ US data-driven analytics
Navigate the evolving US market landscape with advanced analytical solutions, from contracting strategy and product adoption to LOE analysis, co pay optimization, and IRA impact assessment. This end-to-end approach delivers robust, actionable insights that drive measurable results.
✅ RPR stakeholder insights
Empower strategic access and pricing decisions with RPR, a proprietary stakeholder engagement platform. Gain actionable and pressure-tested insights from 3,500+ vetted payers, clinicians, and KOLs across 65 countries – delivered faster and more robustly than traditional primary research methods.
✅ Analogue and landscape research
Establish strategic clarity through rigorous analogue lookbacks and detailed landscape assessments. Tailored secondary research servoces deliver precise benchmarking on pricing, reimbursement decisions, and HTA outcomes – seamlessly integrated with access and pricing, HEOR, and evidence generation expertise to reduce uncertainty and inform effective decision-making.
✅ A&P Flexible Integrated Teams (FIT)
Benefit from adaptable contracting models tailored to your specific needs, or build an agile, extended partnership with an innovative Access & Pricing FIT (Flexible Integrated Team) engagement for long-term strategic collaboration.
Visit Genesisrg.com to find out more, or contact solutions@genesisrg.com to ask how they can help you overcome your challenges.
This content was provided by Genesis Research Group
Company Details
Latest Content from Genesis Research Group
Genesis Research Group RWD / HTA / regulatory / ECA webinar on 15 Feb: reserve your place!
On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar...
Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!
Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...
Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer
International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining...
Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators
Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.
Genesis Research and Clinical Outcomes Solutions announce innovative partnership
International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes...